INNOVIVA, INC. Preferred Stock, Shares Authorized
INNOVIVA, INC. (INVA) had Preferred Stock, Shares Authorized of 230.00 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-05
- 2026-06-30: Preferred Stock, Shares Authorized 230.00K shares.
- 2026-03-31: Preferred Stock, Shares Authorized 230.00K shares.
- 2025-12-31: Preferred Stock, Shares Authorized 230.00K shares.
- 2025-09-30: Preferred Stock, Shares Authorized 230.00K shares.
| Period end | Preferred Stock, Shares Authorized | Preferred Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 230.00K shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 230.00K shares 10-Q · filed 2026-05-06 | |
| 2025-12-31 | 230.00K shares 10-Q · filed 2026-08-05 | |
| 2025-09-30 | 230.00K shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 230.00K shares 10-Q · filed 2025-08-06 | |
| 2025-03-31 | 230.00K shares 10-Q · filed 2025-05-07 | |
| 2024-12-31 | 230.00K shares 10-K · filed 2026-02-25 | |
| 2024-09-30 | 230.00K shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 230.00K shares 10-Q · filed 2024-07-31 | |
| 2024-03-31 | 230.00K shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | 230.00K shares 10-K · filed 2025-02-26 | |
| 2023-09-30 | 230.00K shares 10-Q · filed 2023-11-01 | |
| 2023-06-30 | 230.00K shares 10-Q · filed 2023-08-02 | |
| 2023-03-31 | 230.00K shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 230.00K shares 10-K/A · filed 2024-03-05 | |
| 2022-09-30 | 230.00K shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 230.00K shares 10-Q · filed 2022-07-27 | |
| 2022-03-31 | 230.00K shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 230.00K shares 10-K · filed 2023-02-28 | |
| 2021-09-30 | 230.00K shares 10-Q · filed 2021-10-27 | |
| 2021-06-30 | 230.00K shares 10-Q · filed 2021-07-29 | |
| 2021-03-31 | 230.00K shares 10-Q · filed 2021-04-28 | |
| 2020-12-31 | 230.00K shares 10-K/A · filed 2022-03-17 | |
| 2020-09-30 | 230.00K shares 10-Q · filed 2020-10-28 | |
| 2020-06-30 | 230.00K shares 10-Q · filed 2020-07-29 | |
| 2020-03-31 | 230.00K shares 10-Q · filed 2020-04-29 | |
| 2019-12-31 | 230.00K shares 10-K · filed 2021-02-25 | |
| 2019-09-30 | 230.00K shares 10-Q · filed 2019-10-30 | |
| 2019-06-30 | 230.00K shares 10-Q · filed 2019-07-24 | |
| 2019-03-31 | 230.00K shares 10-Q · filed 2019-05-01 | |
| 2018-12-31 | 230.00K shares 10-K · filed 2020-02-19 | |
| 2018-09-30 | 230.00K shares 10-Q · filed 2018-10-31 | |
| 2018-06-30 | 230.00K shares 10-Q · filed 2018-07-26 | |
| 2018-03-31 | 230.00K shares 10-Q · filed 2018-05-04 | |
| 2017-12-31 | 230.00K shares 10-K · filed 2019-02-19 | |
| 2017-09-30 | 230.00K shares 10-Q · filed 2017-11-03 | |
| 2017-06-30 | 230.00K shares 10-Q · filed 2017-08-08 | |
| 2017-03-31 | 230.00K shares 10-Q · filed 2017-05-05 | |
| 2016-12-31 | 230.00K shares 10-K · filed 2018-02-23 | |
| 2016-09-30 | 230.00K shares 10-Q · filed 2016-11-03 | |
| 2016-06-30 | 230.00K shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 230.00K shares 10-Q · filed 2016-05-05 | |
| 2015-12-31 | 230.00K shares 10-K · filed 2017-02-28 | |
| 2015-09-30 | 230.00K shares 10-Q · filed 2015-11-05 | |
| 2015-06-30 | 230.00K shares 10-Q · filed 2015-08-06 | |
| 2015-03-31 | 230.00K shares 10-Q · filed 2015-05-08 | |
| 2014-12-31 | 230.00K shares 10-K · filed 2016-02-24 | |
| 2013-12-31 | 230.00K shares 10-K · filed 2015-02-27 | 500.00K shares 10-K · filed 2014-03-03 |
| 2012-12-31 | 500.00K shares 10-K · filed 2014-03-03 | 230.00K shares 10-K · filed 2013-02-26 |
| 2011-12-31 | 230.00K shares 10-K · filed 2013-02-26 | |
| 2010-12-31 | 230.00K shares 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |